BLOG / 🇺🇸 United States / corporate governance · · daily

US Executive Compensation Proxy SEC Filings — May 20, 2026

Executive Compensation Insights

By Gunpowder Editorial ·

8 high priority 8 total filings analysed

Executive Summary

This intelligence stream analyzes 8 DEF 14A proxy filings for the 2026 annual meeting season, revealing a concentrated focus on capital structure management and governance transitions.

A dominant theme is the prevalence of reverse stock split proposals (Longeveron, Oragenics) and share issuance authorizations (Blink Charging, MSC Income Fund), signaling that several small-cap and micro-cap companies are actively managing stock price compliance or raising capital. Insider trading activity is notably absent across all filings, providing no direct management conviction signals. Period-over-period comparisons are largely unavailable as these proxy statements focus on governance proposals rather than financial performance. However, the filings reveal a clear pattern of companies seeking to increase equity incentives (Blink Charging, Workhorse) and authorize below-NAV share sales (MSC Income Fund), indicating a focus on retaining talent and accessing capital markets. The most critical development is the high concentration of annual meetings in late June 2026, creating a catalyst calendar for governance votes that could impact stock liquidity and dilution. Overall, the filings suggest a cautious capital allocation environment with an emphasis on survival and flexibility rather than aggressive growth.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: DEF 14A

Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from May 19, 2026.

Investment Signals (8)

  • Blink Charging Co. ↓
    ▲

    Proposes increasing share reserve under 2018 Incentive Compensation Plan by 10M shares (to 17M total), a 143% increase. This signals aggressive equity-based compensation for talent retention in the competitive EV charging sector [BULLISH for talent retention, BEARISH for dilution]

  • Longeveron Inc. ↓
    ▲

    Proposes reverse stock split (1:2 to 1:20) alongside increasing authorized Class A common stock. This dual proposal suggests preparation for potential Nasdaq compliance and future capital raises, typical of pre-revenue biotech firms [NEUTRAL with upside catalyst if compliance achieved]

  • ORAGENICS INC ↓
    ▲

    Proposes reverse stock split at ratio between 1:2 and 1:50, the widest range among all filings, indicating maximum flexibility for stock price management. Also has non-voting convertible preferred shares outstanding, creating potential overhang [BEARISH for existing common shareholders]

  • Workhorse Group Inc. ↓ (NEUTRAL)
    ▲

    Proposes Amended and Restated 2023 Long-Term Incentive Plan, indicating need to refresh equity compensation for key employees in the struggling EV truck sector. Board unanimously recommends FOR on all proposals, showing unified governance

  • MSC Income Fund, Inc. ↓
    ▲

    Proposes authorization to sell shares below net asset value (NAV) over next 12 months. This is a significant signal of capital needs and potential NAV dilution for existing shareholders, common for BDCs seeking growth capital [BEARISH for NAV-focused investors]

  • T Stamp Inc. ↓
    ▲

    Proposes ratification of issuance of up to 648,148 shares upon exercise of Private Placement Warrants to Armistice Capital Master Fund Ltd. This signals a specific, pre-arranged dilution event tied to a single institutional investor [NEUTRAL with watch on Armistice's exercise intentions]

  • EUROPEAN EQUITY FUND, INC / MD ↓
    ▲

    Transitioning to a declassified board by 2028, with all directors standing for election annually. This governance improvement enhances shareholder accountability and aligns with best practices [BULLISH for governance]

  • CENTRAL & EASTERN EUROPE FUND, INC. and The New Germany Fund, Inc. ↓ (NEUTRAL)
    ▲

    Joint proxy filing for director elections and auditor ratification. The lack of any capital allocation or compensation proposals suggests stable, passive management structures typical of closed-end funds

Risk Flags (8)

  • Longeveron Inc./Dilution Risk↓ [HIGH RISK]
    ▼

    Proposing both a reverse stock split (up to 1:20) and increase in authorized Class A common stock. This combination could lead to significant shareholder dilution if the authorized shares are issued post-split

  • ORAGENICS INC/Wide Reverse Split Range↓ [HIGH RISK]
    ▼

    The 1:2 to 1:50 reverse split range is unusually broad, giving the board extreme discretion. Combined with non-voting convertible preferred shares, common shareholders face unpredictable capital structure changes

  • Blink Charging Co./Equity Dilution↓ [MEDIUM RISK]
    ▼

    The 10M share increase in the incentive plan (143% increase) represents potential dilution of ~7% of current outstanding shares (143.65M). This is a material dilution event for existing shareholders

  • MSC Income Fund, Inc./NAV Dilution↓ [HIGH RISK]
    ▼

    Authorization to sell shares below NAV per share is a direct risk to existing shareholders' book value. This is a common but significant risk for BDC investors

  • T Stamp Inc./Warrant Dilution↓ [MEDIUM RISK]
    ▼

    The specific issuance of 648,148 shares to Armistice Capital (a single institutional investor) creates a known dilution event. If Armistice exercises all warrants, it represents ~11.6% of current Class A shares outstanding (5.6M)

  • Workhorse Group Inc./EV Sector Headwinds↓ [MEDIUM RISK]
    ▼

    Proposing refreshed LTIP in a challenging EV truck market. The company's ongoing cash burn and need for equity incentives suggests financial stress and potential future dilution

  • EUROPEAN EQUITY FUND, INC /MD/Quorum Risk↓ [LOW RISK]
    ▼

    Requires one-third of all votes entitled to be cast for quorum, with abstentions and broker non-votes counting as votes 'against' director elections. This could lead to failed elections if retail turnout is low

  • CENTRAL & EASTERN EUROPE FUND, INC./Geopolitical Risk↓ [LOW RISK]
    ▼

    As a fund focused on Central and Eastern Europe, ongoing geopolitical tensions in the region could impact portfolio valuations, though not directly addressed in the proxy

Opportunities (8)

  • Blink Charging Co./Incentive Alignment↓
    ◆

    The 10M share increase in the incentive plan could attract and retain top talent in the growing EV charging market. If execution improves, the dilution could be offset by revenue growth [OPPORTUNITY for long-term holders]

  • Workhorse Group Inc./Turnaround Potential↓
    ◆

    The refreshed LTIP could incentivize management to achieve operational milestones. If the company secures new EV contracts, the current low share price could offer asymmetric upside [OPPORTUNITY for speculative investors]

  • EUROPEAN EQUITY FUND, INC /MD/Governance Upgrade↓ (OPPORTUNITY)
    ◆

    The transition to a declassified board by 2028 is a positive governance trend that could attract ESG-focused investors and potentially narrow the discount to NAV

  • MSC Income Fund, Inc./Growth Capital Access↓
    ◆

    The below-NAV issuance authorization provides flexibility to raise capital for new investments. If deployed into high-yielding assets, it could boost net investment income over time [OPPORTUNITY for income-focused investors]

  • Longeveron Inc./Reverse Split Catalyst↓ (OPPORTUNITY)
    ◆

    If the reverse split is executed and the company achieves Nasdaq compliance, it could remove a major overhang and attract institutional investors who were previously restricted

  • ORAGENICS INC/Strategic Flexibility↓
    ◆

    The wide reverse split range gives the board maximum flexibility to manage stock price. If combined with positive clinical trial results, a reverse split could precede a significant re-rating [OPPORTUNITY for biotech speculators]

  • T Stamp Inc./Institutional Backing↓ (OPPORTUNITY)
    ◆

    The specific warrant issuance to Armistice Capital indicates institutional interest. If Armistice exercises and becomes a larger shareholder, it could provide strategic support

  • CENTRAL & EASTERN EUROPE FUND, INC./Value Play↓ (OPPORTUNITY)
    ◆

    Closed-end funds trading at discounts to NAV could offer value if the discount narrows. The joint proxy filing with New Germany Fund suggests potential for future consolidation or cost synergies

Sector Themes (5)

  • Micro-Cap Capital Structure Management
    ◆

    3 of 8 filings (Longeveron, Oragenics, T Stamp) involve reverse stock splits or warrant issuances, highlighting the prevalence of capital structure management among micro-cap and pre-revenue companies. This suggests many small companies are struggling with stock price compliance and cash needs.

  • Equity Incentive Expansion
    ◆

    2 of 8 filings (Blink Charging, Workhorse) propose significant increases in equity incentive plan shares. This trend indicates that companies in growth/restructuring phases are using equity compensation to preserve cash while attracting talent, a common pattern in capital-intensive sectors like EV and biotech.

  • Governance Modernization
    ◆

    2 of 8 filings (European Equity Fund, MSC Income Fund) include governance improvements (declassified board, shareholder authorization for below-NAV sales). This reflects a broader push for shareholder-friendly governance, though the below-NAV proposal is a double-edged sword.

  • Closed-End Fund Stability
    ◆

    2 of 8 filings (European Equity Fund, Central & Eastern Europe Fund) are from closed-end funds with minimal capital structure changes. Their proxies focus on routine director elections and auditor ratification, indicating stable, passive management structures with low event risk.

  • Concentrated Meeting Calendar
    ◆

    5 of 8 annual meetings are scheduled for late June 2026 (June 29-30), creating a concentrated period of governance votes. This could lead to increased volatility for these stocks around their respective meeting dates as vote outcomes are announced.

Watch List (8)

Filing Analyses (8)
Longeveron Inc. DEF 14A neutral materiality 5/10

20-05-2026

Longeveron Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on July 1, 2026. Key proposals include electing three directors, increasing authorized Class A common stock, authorizing a reverse stock split (1:2 to 1:20), amending the 2021 Incentive Award Plan to increase authorized shares, and ratifying CBIZ CPAs P.C. as independent auditor for fiscal year 2026. The filing does not disclose financial results or performance metrics, so no positive or negative trends can be assessed from this document alone.

  • · Record date for voting is May 11, 2026.
  • · Class A common stock holders have 1 vote per share; Class B common stock holders have 5 votes per share.
  • · A quorum requires at least one-third of issued and outstanding shares representing a majority of votes entitled to be cast.
  • · Proposal 2 seeks to increase authorized Class A common stock shares (amount not specified).
  • · Proposal 3 authorizes a reverse stock split at a ratio ranging from 1:2 to 1:20, with exact ratio set by the Board.
  • · Proposal 4 seeks to increase shares authorized under the 2021 Incentive Award Plan (amount not specified).
  • · Proposal 6 allows adjournment if needed to solicit additional votes for Proposals 2 or 3.
ORAGENICS INC DEF 14A neutral materiality 8/10

20-05-2026

Oragenics, Inc. filed a DEF 14A proxy statement for the 2025 Annual Meeting of Shareholders to be held virtually on June 29, 2026. Key proposals include election of six directors (Proposal 1), a non-binding advisory vote on executive compensation (Proposal 2), authorization for the Board to effect a reverse stock split at a ratio between 1:2 and 1:50 within one year of shareholder approval (Proposal 3), and ratification of Cherry Bekaert LLP as independent auditors for FY2026 (Proposal 4). The company had 4,511,957 shares of common stock outstanding as of the record date of April 27, 2026, with additional Series F and Series H convertible preferred shares outstanding but non-voting.

  • · The Annual Meeting will be held virtually on June 29, 2026 at 10:00 a.m. Eastern Time.
  • · Proxy materials first disseminated to shareholders on or about May 20, 2026.
  • · Shareholders of record as of April 27, 2026 are entitled to vote.
  • · The reverse stock split ratio range authorized would be between 1:2 and 1:50, with the exact ratio determined by the Board and announced publicly.
  • · The Series F and Series H Convertible Preferred Stock are not entitled to vote at the Annual Meeting.
  • · If all Series H warrants were exercised and the underlying Series H preferred converted, approximately 23,925,000 additional common shares could be issued.
  • · The board recommends a vote FOR all four proposals.
  • · The fiscal year ended December 31, 2025 annual report is available alongside the proxy statement.
T Stamp Inc DEF 14A neutral materiality 5/10

20-05-2026

T Stamp Inc. filed a definitive proxy statement (DEF 14A) for its deferred 2025 Annual Meeting to be held virtually on July 7, 2026. Stockholders will vote on three proposals: election of two Class III directors, ratification of CBIZ CPAs P.C. as independent auditor for FY2025, and ratification of the issuance of up to 648,148 shares of Class A Common Stock upon exercise of Private Placement Warrants issued to Armistice Capital Master Fund Ltd. The record date is May 13, 2026, with 5,599,964 shares of Class A Common Stock outstanding. No financial performance data or period-over-period comparisons are included in this filing.

  • · The deferred 2025 Annual Meeting will be held entirely online via live audio webcast at https://vote.colonialstock.com/tstamp2025_3.
  • · Proposal 1 seeks to elect two Class III directors to serve until the 2028 Annual Meeting.
  • · Proposal 2 ratifies CBIZ CPAs P.C. as independent registered public accounting firm for fiscal year ending December 31, 2025.
  • · Proposal 3 ratifies the issuance of Private Placement Warrants (Series A for 370,370 shares and Series B for 277,778 shares) at $8.10 per share, issued under the Securities Purchase Agreement dated December 5, 2024 with Armistice Capital Master Fund Ltd., as required by Nasdaq Listing Rule 5635(d).
  • · Proposal 1 and Proposal 3 are considered 'non-routine' items; brokers may not vote on them without instructions from beneficial holders.
  • · Proxy materials will be furnished to stockholders on or about May 26, 2026.
  • · The filing is an amendment (No. 2) to the original Schedule 14A filed January 22, 2026, updating the meeting date, time, and record date.
EUROPEAN EQUITY FUND, INC / MD DEF 14A neutral materiality 4/10

20-05-2026

The European Equity Fund, Inc. (EEA) filed a definitive proxy statement (DEF 14A) for its Annual Meeting of Stockholders scheduled for June 30, 2026. The meeting will seek stockholder approval to elect two Class III Directors (Bernhard Koepp and Dr. Wolfgang Leoni) to one-year terms and to ratify the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026. The filing also notes a transition to a declassified board, with all directors standing for election annually by 2028.

  • · Record date for voting is May 15, 2026; proxy materials to be mailed on or about May 27, 2026.
  • · A quorum requires one-third of all votes entitled to be cast.
  • · Election of directors requires a majority of total votes entitled to be cast (abstentions and broker non-votes count as votes 'against').
  • · Ratification of auditor requires a majority of votes cast (abstentions and broker non-votes are disregarded).
  • · The Fund's charter was amended in 2025 to declassify the board over three years; Class III terms expire at this 2026 meeting, Class I and III in 2027, and all classes in 2028.
  • · The Board may fill vacancies by majority vote of remaining directors even if less than a quorum.
Workhorse Group Inc. DEF 14A neutral materiality 5/10

20-05-2026

Workhorse Group Inc. filed its DEF 14A proxy statement on May 20, 2026, for the 2026 Annual Meeting of Stockholders to be held virtually on June 29, 2026. The meeting will include votes on four proposals: election of seven director nominees, advisory approval of named executive officer compensation, ratification of Carr, Riggs & Ingram as independent auditors for FY2026, and approval of the Amended and Restated 2023 Long-Term Incentive Plan. The Board unanimously recommends a 'FOR' vote on all proposals. As of the May 8, 2026 record date, there were 10,893,400 shares of common stock outstanding and entitled to vote.

  • · The annual meeting will be held virtually on June 29, 2026 at 9:00 a.m. Eastern Time at www.virtualshareholdermeeting.com/WKHS2026.
  • · Proxy materials are being made available beginning on or about May 20, 2026.
  • · Stockholders of record at the close of business on May 8, 2026 are entitled to vote.
  • · The company is taking advantage of SEC rules to furnish proxy materials via the Internet.
  • · Proposal 3 (ratification of auditors) is considered a routine matter; Proposals 1, 2, and 4 are non-routine.
  • · Broker non-votes will have no effect on Proposals 1, 2, and 4 but uninstructed shares may be voted on Proposal 3 at the broker's discretion.
  • · The company's forward-looking statements include risks related to capital raising, cost reduction, vehicle delivery, new product development, and Nasdaq compliance.
MSC INCOME FUND, INC. DEF 14A neutral materiality 5/10

20-05-2026

MSC Income Fund, Inc. filed its definitive proxy statement (DEF 14A) on May 20, 2026, for the 2026 Annual Meeting of Stockholders to be held on August 5, 2026. The meeting will include the election of directors for a one-year term and a proposal to authorize the Board to offer and sell shares of common stock at a price below net asset value per share over the next 12 months, subject to certain limitations. As of the record date of May 18, 2026, the company had 45,345,229 shares of common stock outstanding.

  • · The annual meeting will be held on August 5, 2026, at 9:00 AM local time in the South Conference Room at 1330 Post Oak Boulevard, 2nd Floor, Houston, Texas 77056.
  • · Stockholders of record as of May 18, 2026 are entitled to vote.
  • · The Board recommends voting FOR the election of each director nominee and FOR the Below-NAV Share Issuance Proposal.
  • · If a quorum is not established, the Chairman may adjourn the meeting to a date not more than 120 days after the record date.
CENTRAL & EASTERN EUROPE FUND, INC. DEF 14A neutral materiality 3/10

20-05-2026

The Central and Eastern Europe Fund, Inc. (CEE) and The New Germany Fund, Inc. (GF) filed a joint definitive proxy statement (DEF 14A) for their 2026 Annual Meeting of Stockholders to be held on June 30, 2026. The meeting will consider the election of directors (two for CEE, one for GF) and ratification of Ernst & Young LLP as independent auditors. As of May 15, 2026, CEE had 6,520,194.51 shares outstanding and GF had 16,231,237.85 shares outstanding. No financial results or performance metrics are disclosed in this filing.

  • · Record date for voting: May 15, 2026.
  • · Meeting date: June 30, 2026 at 1:30 p.m. New York time.
  • · Proxies first mailed on or about May 27, 2026.
  • · Quorum requirement: one-third of votes entitled to be cast.
  • · Director election requires majority of votes entitled to be cast (abstentions and broker non-votes count as against).
  • · Auditor ratification requires majority of votes cast.
  • · CEE fiscal year ends October 31; GF fiscal year ends December 31.

Get daily alerts with 8 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 8 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Executive Compensation Proxy SEC Filings

May 27, 2026

US Executive Compensation Proxy SEC Filings — May 27, 2026

May 26, 2026

US Executive Compensation Proxy SEC Filings — May 26, 2026

May 22, 2026

US Executive Compensation Proxy SEC Filings — May 22, 2026

May 18, 2026

US Executive Compensation Proxy SEC Filings — May 18, 2026

🇺🇸 More from United States

View all →

May 28, 2026

US Pre-Market SEC Filings Roundup — May 28, 2026

US Pre-Market SEC Filings Roundup

May 27, 2026

US Pre-Market SEC Filings Roundup — May 27, 2026

US Pre-Market SEC Filings Roundup

May 27, 2026

S&P 500 Technology Sector SEC Filings — May 27, 2026

S&P 500 Technology Sector SEC Filings

May 27, 2026

Orphan Drug Approvals — May 27, 2026

Orphan Drug Approvals
← All United States digests